Oncotarget
The cover for issue 44 of Oncotarget features Figure 1, "Schematic diagram of the human IGF2 gene structure," by Radhakrishnan, et al.
MEK inhibitors in non-V600 BRAF mutations and fusions |
https://doi.org/10.18632/oncotarget.27788 Douglas B. Johnson, Caroline A. Nebhan, and Marcus S. Noel |
3900-3903 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Methylation of a newly identified region of the INS-IGF2 gene determines IGF2 expression in breast cancer tumors and in breast cancer cells |
https://doi.org/10.18632/oncotarget.27655 Vinodh Kumar Radhakrishnan, Kameswaran Ravichandran, Chibuzo Eke, Amanda Ortiz-Vicil, Qianwei Tan, Marino De León, and Daisy D. De León |
3904-3920 |
Abstract | PDF | Full Text | How to cite | Press Release | Podcast | Order a Reprint |
MEK is a promising target in the basal subtype of bladder cancer |
https://doi.org/10.18632/oncotarget.27767 Nathan M. Merrill, Nathalie M. Vandecan, Kathleen C. Day, Phillip L. Palmbos, Mark L. Day, Aaron M. Udager, Sofia D. Merajver, and Matthew B. Soellner |
3921-3932 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Effect of eflornithine on mutation frequency in temozolomide-treated U87MG cells |
https://doi.org/10.18632/oncotarget.27782 Noymi Yam, Jason Levin, Zhengzheng Bao, Wubin Qian, and Victor A. Levin |
3933-3942 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Evaluations of CRC2631 toxicity, tumor colonization, and genetic stability in the TRAMP prostate cancer model |
https://doi.org/10.18632/oncotarget.27769 Robert A. Kazmierczak, Bakul Dhagat-Mehta, Elke Gulden, Li Lee, Lixin Ma, Clintin P. Davis-Stober, Austen A. Barnett, and Yves C. Chabu |
3943-3958 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas |
https://doi.org/10.18632/oncotarget.27784 Geraldine O'Sullivan Coyne, Shivaani Kummar, Robert S. Meehan, Khanh Do, Jerry M. Collins, Larry Anderson, Kazusa Ishii, Naoko Takebe, Jennifer Zlott, Lamin Juwara, Richard Piekarz, Howard Streicher, Elad Sharon, Larry Rubinstein, Andrea Regier Voth, Jay Lozier, Angie B. Dull, Deborah Wilsker, Toshinori Hinoue, Peter W. Laird, Katherine V. Ferry-Galow, Robert J. Kinders, Ralph E. Parchment, James H. Doroshow, and Alice P. Chen |
3959-3971 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors |
https://doi.org/10.18632/oncotarget.27772 Michael R. Mortensen, Jacqueline Mock, Marco Bertolini, Marco Stringhini, Marco Catalano, and Dario Neri |
3972-3983 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Anti-tumor activities of the new oral pan-RAF inhibitor, TAK-580, used as monotherapy or in combination with novel agents in multiple myeloma |
https://doi.org/10.18632/oncotarget.27775 Rikio Suzuki, Yuka Kitamura, Yoshihiko Nakamura, Hibiki Akashi, Yoshiaki Ogawa, Hiroshi Kawada, and Kiyoshi Ando |
3984-3997 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Histo-molecular differentiation of renal cancer subtypes by mass spectrometry imaging and rapid proteome profiling of formalin-fixed paraffin-embedded tumor tissue sections |
https://doi.org/10.18632/oncotarget.27787 Uwe Möginger, Niels Marcussen, and Ole N. Jensen |
3998-4015 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Detection of BRAF splicing variants in plasma-derived cell-free nucleic acids and extracellular vesicles of melanoma patients failing targeted therapy therapies |
https://doi.org/10.18632/oncotarget.27790 Michael E. Clark, Helen Rizos, Michelle R. Pereira, Ashleigh C. McEvoy, Gabriela Marsavela, Leslie Calapre, Katie Meehan, Olivia Ruhen, Muhammad A. Khattak, Tarek M. Meniawy, Georgina V. Long, Matteo S. Carlino, Alexander M. Menzies, Michael Millward, Melanie Ziman, and Elin S. Gray |
4016-4027 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Evidence for functional and regulatory cross-talk between Wnt/β-catenin signalling and Mre11–Rad50–Nbs1 complex in the repair of cisplatin-induced DNA cross-links |
https://doi.org/10.18632/oncotarget.27777 Sanjeev Pasadi, and Kalappa Muniyappa |
4028-4044 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine |
https://doi.org/10.18632/oncotarget.27785 Niraj Lodhi, Moe Tun, Poonam Nagpal, Arati A. Inamdar, Nehad M. Ayoub, Noor Siyam, Lucia Oton-Gonzalez, Angela Gerona, Dainelle Morris, Rana Sandhu, and Kwangsun Stephen Suh |
4045-4073 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Correction: Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling |
https://doi.org/10.18632/oncotarget.27779 Bridgette F. Peake, Siobhan M. Eze, Lily Yang, Robert C. Castellino, and Rita Nahta |
4074-4075 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC